source
- Parabilis Medicines raises $670 million in record-setting biotech IPO on NasdaqParabilis Medicines, a Cambridge, Massachusetts drug developer, completed its initial public offering on Nasdaq, raising $670 million. The offering is described as the largest biotech IPO in indus…
- Parabilis raises $670M in record-setting Nasdaq debut to fund cancer drug developmentParabilis completed a $670 million initial public offering on the Nasdaq, establishing the largest biotech debut in the exchange’s history. The offering drew strong investor demand even as attenti…